Antibody data
- Antibody Data
- Antigen structure
- References [10]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 18374-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- ANGPTL4 antibody
- Antibody type
- Polyclonal
- Description
- ANGPTL4 antibody (Cat. #18374-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IF, IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Allobaculum Involves in the Modulation of Intestinal ANGPTLT4 Expression in Mice Treated by High-Fat Diet.
Baicalein Enhances the Effect of Acarbose on the Improvement of Nonalcoholic Fatty Liver Disease Associated with Prediabetes via the Inhibition of De Novo Lipogenesis.
Banxia Baizhu Tianma decoction attenuates obesity-related hypertension.
Decreased ANGPTL4 impairs endometrial angiogenesis during peri-implantation period in patients with recurrent implantation failure.
Angiopoietin-Like Protein 4 (ANGPTL4) Induces Retinal Pigment Epithelial Barrier Breakdown by Activating Signal Transducer and Activator of Transcription 3 (STAT3): Evidence from ARPE-19 Cells Under Hypoxic Condition and Diabetic Rats.
The long non-coding RNA PVT1 represses ANGPTL4 transcription through binding with EZH2 in trophoblast cell.
ANGPTL4 promotes the progression of cutaneous melanoma to brain metastasis.
Hypoxia-induced angiopoietin-like protein 4 as a clinical biomarker and treatment target for human prostate cancer.
ANGPTL4-αvβ3 interaction counteracts hypoxia-induced vascular permeability by modulating Src signalling downstream of vascular endothelial growth factor receptor 2.
An integrated genomic approach identifies persistent tumor suppressive effects of transforming growth factor-β in human breast cancer.
Zheng Z, Lyu W, Ren Y, Li X, Zhao S, Yang H, Xiao Y
Frontiers in nutrition 2021;8:690138
Frontiers in nutrition 2021;8:690138
Baicalein Enhances the Effect of Acarbose on the Improvement of Nonalcoholic Fatty Liver Disease Associated with Prediabetes via the Inhibition of De Novo Lipogenesis.
Xing Y, Ren X, Li X, Sui L, Shi X, Sun Y, Quan C, Xiu Z, Dong Y
Journal of agricultural and food chemistry 2021 Sep 1;69(34):9822-9836
Journal of agricultural and food chemistry 2021 Sep 1;69(34):9822-9836
Banxia Baizhu Tianma decoction attenuates obesity-related hypertension.
Jiang YH, Zhang P, Tao Y, Liu Y, Cao G, Zhou L, Yang CH
Journal of ethnopharmacology 2021 Feb 10;266:113453
Journal of ethnopharmacology 2021 Feb 10;266:113453
Decreased ANGPTL4 impairs endometrial angiogenesis during peri-implantation period in patients with recurrent implantation failure.
Li M, Hu J, Yao L, Gao M
Journal of cellular and molecular medicine 2020 Sep;24(18):10730-10743
Journal of cellular and molecular medicine 2020 Sep;24(18):10730-10743
Angiopoietin-Like Protein 4 (ANGPTL4) Induces Retinal Pigment Epithelial Barrier Breakdown by Activating Signal Transducer and Activator of Transcription 3 (STAT3): Evidence from ARPE-19 Cells Under Hypoxic Condition and Diabetic Rats.
Yang X, Cao J, Du Y, Gong Q, Cheng Y, Su G
Medical science monitor : international medical journal of experimental and clinical research 2019 Sep 8;25:6742-6754
Medical science monitor : international medical journal of experimental and clinical research 2019 Sep 8;25:6742-6754
The long non-coding RNA PVT1 represses ANGPTL4 transcription through binding with EZH2 in trophoblast cell.
Xu Y, Lian Y, Zhang Y, Huang S, Zuo Q, Yang N, Chen Y, Wu D, Sun L
Journal of cellular and molecular medicine 2018 Feb;22(2):1272-1282
Journal of cellular and molecular medicine 2018 Feb;22(2):1272-1282
ANGPTL4 promotes the progression of cutaneous melanoma to brain metastasis.
Izraely S, Ben-Menachem S, Sagi-Assif O, Meshel T, Marzese DM, Ohe S, Zubrilov I, Pasmanik-Chor M, Hoon DSB, Witz IP
Oncotarget 2017 Sep 29;8(44):75778-75796
Oncotarget 2017 Sep 29;8(44):75778-75796
Hypoxia-induced angiopoietin-like protein 4 as a clinical biomarker and treatment target for human prostate cancer.
Hata S, Nomura T, Iwasaki K, Sato R, Yamasaki M, Sato F, Mimata H
Oncology reports 2017 Jul;38(1):120-128
Oncology reports 2017 Jul;38(1):120-128
ANGPTL4-αvβ3 interaction counteracts hypoxia-induced vascular permeability by modulating Src signalling downstream of vascular endothelial growth factor receptor 2.
Gomez Perdiguero E, Liabotis-Fontugne A, Durand M, Faye C, Ricard-Blum S, Simonutti M, Augustin S, Robb BM, Paques M, Valenzuela DM, Murphy AJ, Yancopoulos GD, Thurston G, Galaup A, Monnot C, Germain S
The Journal of pathology 2016 Dec;240(4):461-471
The Journal of pathology 2016 Dec;240(4):461-471
An integrated genomic approach identifies persistent tumor suppressive effects of transforming growth factor-β in human breast cancer.
Sato M, Kadota M, Tang B, Yang HH, Yang YA, Shan M, Weng J, Welsh MA, Flanders KC, Nagano Y, Michalowski AM, Clifford RJ, Lee MP, Wakefield LM
Breast cancer research : BCR 2014 Jun 2;16(3):R57
Breast cancer research : BCR 2014 Jun 2;16(3):R57
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- HEK-293 cells were subjected to SDS PAGE followed by western blot with 18374-1-AP(ANGPTL4 antibody) at dilution of 1:1000
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The ANGPTL4 antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human ANGPTL4. This antibody recognizes human, mouse antigen. The ANGPTL4 antibody has been validated for the following applications: ELISA, WB, IHC, IF analysis.